This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Standalone Sep 2026 quarter revenue Rs 6.75 lakh versus nil; after-tax loss Rs 1.01 lakh
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
By the next day the stock moved 3.5 pts less than Nifty Microcap 250 and 1.1 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Standalone quarter ended 30 September 2026: revenue Rs 6.75 lakh versus nil in the same quarter of 2025; loss after tax Rs 1.01 lakh versus Rs 48.33 lakh. Half-year standalone revenue was Rs 12.40 lakh versus Rs 12.00 lakh, and loss after tax Rs 4.20 lakh versus Rs 41.27 lakh. The year-ago quarter loss included Rs 47.20 lakh exceptional items. Equity was negative Rs 226.00 lakh with Rs 33.20 lakh borrowings. The review found no material misstatement.
Revenue has moved from nil, but continuing losses, negative equity and borrowings keep financial risk high despite positive operating cash flow.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹0.07 Cr | ₹0.00 Cr | turned positive |
| Operating profit | −₹0.04 Cr | −₹0.01 Cr | loss widened |
| Profit after tax | −₹0.01 Cr | −₹0.48 Cr | loss narrowed |
| EBITDA margin | -52.6% | — | — |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.